Cargando…

Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients

BACKGROUND: In China, upper tract urothelial carcinoma (UTUC) is less prevalent but more malignant in males. This study investigates the prognostic factors and causes of gender-based differences in Chinese populations. METHODS: Between 1999 and 2011, 687 UTUC patients who underwent surgery were util...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Gengyan, Yao, Lin, Hong, Peng, Yang, Li, Ci, Weimin, Liu, Libo, He, Qun, Gong, Kan, Li, Xuesong, Zhou, Liqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284533/ https://www.ncbi.nlm.nih.gov/pubmed/30584358 http://dx.doi.org/10.2147/CMAR.S178554

Ejemplares similares

Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy
por: Zhong, Wenlong, et al.
Publicado: (2017)

Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma
por: Lu, Huan, et al.
Publicado: (2020)

Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation
por: Zhang, Lei, et al.
Publicado: (2015)

The Influence of Tumor Size on Oncologic Outcomes for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy
por: Su, Xiaohong, et al.
Publicado: (2016)

Role of lymph node dissection in the management of upper tract urothelial carcinomas: a meta-analysis
por: Guo, Runqi, et al.
Publicado: (2018)

AB87. Evaluating the impact of preoperative anemia on the prognosis of upper tract urothelial carcinoma following radical nephroureterectomy
por: Xing, Yunchao, et al.
Publicado: (2014)

Toward clinical understanding of aristolochic acid upper-tract urothelial carcinoma
por: Boot, Arnoud, et al.
Publicado: (2020)

AB90. Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of methylation status
por: Zhang, Lei, et al.
Publicado: (2014)

AB162. Prognostic and predictive value of epigenetic biomarkers and clinical factors in upper tract urothelial carcinoma
por: Xiong, Gengyan, et al.
Publicado: (2015)

Latency period of aristolochic acid-induced upper urinary tract urothelial carcinoma
por: Jhuang, Jing-Rong, et al.
Publicado: (2023)

Aristolochic Acid Affects Upper Tract Urothelial Cancer Behavior through the MAPK Pathway
por: Chen, I-Hsuan, et al.
Publicado: (2019)

AB121. The prognostic impact of squamous and glandular differentiation for upper tract urothelial carcinoma patients after radical nephroureterectomy
por: Tang, Qi, et al.
Publicado: (2015)

Comparison of clinicopathologic characteristics, epigenetic biomarkers and prognosis between renal pelvic and ureteral tumors in upper tract urothelial carcinoma
por: Fang, Dong, et al.
Publicado: (2018)

AB133. Predictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from a nationwide high volume center of China
por: Xiong, Gengyan, et al.
Publicado: (2014)

AB93. Prognostic and predictive value of epigenetic biomarkers in upper tract urothelial carcinoma: a large-scale multi-gene promoter methylation analysis
por: Xiong, Gengyan, et al.
Publicado: (2014)

Copy Number Signatures and Clinical Outcomes in Upper Tract Urothelial Carcinoma
por: Guan, Bao, et al.
Publicado: (2021)

Risk Factors for Unfavorable Pathological Types of Intravesical Recurrence in Patients With Upper Urinary Tract Urothelial Carcinoma Following Radical Nephroureterectomy
por: Zhu, Jun, et al.
Publicado: (2022)

High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy
por: Shi, Bentao, et al.
Publicado: (2015)

AB063. Comparisons of prognosis between urothelial carcinoma of the upper urinary tract and bladder with pT3-4 diseases
por: Su, Xiaohong, et al.
Publicado: (2016)

Lynch syndrome and exposure to aristolochic acid in upper-tract urothelial carcinoma: its clinical impact?
por: Colin, Pierre, et al.
Publicado: (2016)

Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposure
por: Karanović, Sandra, et al.
Publicado: (2021)

Positive urinary fluorescence in situ hybridization indicates poor prognosis in patients with upper tract urothelial carcinoma
por: Guan, Bao, et al.
Publicado: (2018)

AB92. Prevalence and factors associated with baseline chronic kidney disease in China: a 10-year study of 785 upper urinary tract urothelial carcinoma patients
por: Xiong, Gengyan, et al.
Publicado: (2014)

Differential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo
por: TAO, LE, et al.
Publicado: (2015)

Surgical techniques and oncological outcomes of pure transperitoneal laparoscopic radical nephroureterectomy for upper urinary tract urothelial carcinoma
por: Yuan, Changwei, et al.
Publicado: (2023)

Comparison between completely and traditionally retroperitoneoscopic nephroureterectomy for upper tract urothelial cancer
por: Yao, Lin, et al.
Publicado: (2016)

Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma complicated with aristolochic acid nephropathy after radical nephroureterectomy
por: Shan, Hongli, et al.
Publicado: (2020)

Chinese Herbs Containing Aristolochic Acid Associated with Renal Failure and Urothelial Carcinoma: A Review from Epidemiologic Observations to Causal Inference
por: Yang, Hsiao-Yu, et al.
Publicado: (2014)

AB91. Risk factors and treatment outcomes of new contralateral upper urinary urothelial carcinoma after nephroureterectomy: the experiences of a large Chinese center
por: Fang, Dong, et al.
Publicado: (2014)

Nomogram Predicting Renal Insufficiency after Nephroureterectomy for Upper Tract Urothelial Carcinoma in the Chinese Population: Exclusion of Ineligible Candidates for Adjuvant Chemotherapy
por: Fang, Dong, et al.
Publicado: (2014)

Patient‐Derived Upper Tract Urothelial Carcinoma Organoids as a Platform for Drug Screening
por: Li, Zhichao, et al.
Publicado: (2021)

The Evolution of Clinicopathological Diagnostic Features of Upper Tract Urothelial Carcinoma in China: A Summary of 2561 Cases in the Last 20 Years
por: Xu, Chunru, et al.
Publicado: (2022)

High Preoperative Controlling Nutritional Status Score Predicts a Poor Prognosis in Patients with Localized Upper Tract Urothelial Cancer: A Propensity Score Matching Study in a Large Chinese Center
por: Bao, Zhengqing, et al.
Publicado: (2020)

AB113. Comparisons of prognosis between urothelial carcinoma of the upper urinary tract and bladder with pT3-4 diseases
por: Su, Xiaohong, et al.
Publicado: (2015)

Identification of Germline Mutations in Upper Tract Urothelial Carcinoma With Suspected Lynch Syndrome
por: Guan, Bao, et al.
Publicado: (2022)

Increased Expression Of SOX2 Predicts A Poor Prognosis And Promotes Malignant Phenotypes In Upper Tract Urothelial Carcinoma
por: Bao, Zhengqing, et al.
Publicado: (2019)

The Significance of Preoperative Serum Sodium and Hemoglobin in Outcomes of Upper Tract Urothelial Carcinoma: Multi-Center Analysis Between China and the United States
por: Fang, Dong, et al.
Publicado: (2020)

Aristolochic Acid and Immunotherapy for Urothelial Carcinoma: Directions for unmet Needs
por: Yang, Huang-Yu, et al.
Publicado: (2019)

Comparative Analysis of Aristolochic Acids in Aristolochia Medicinal Herbs and Evaluation of Their Toxicities
por: Zhang, Shu-Han, et al.
Publicado: (2022)

Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma
por: Li, Xiaoying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qup5qe2hfn5u2suae70il3suoj